BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BRL-305 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of BRL-305\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07248176-3156@assetmemo.bio
DTSTAMP:20261121T005834Z
DTSTART;VALUE=DATE:20270315
DTEND;VALUE=DATE:20270316
SUMMARY:BRL-305: Phase na readout est. (NCT07248176)
DESCRIPTION:BRL-305\, phase na\, Multiple Myeloma.\nStudy: Universal CAR-T 
 Cell Therapy for MM\nEstimated primary completion: 15 March 2027. This is 
 a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can 
 move.\nDrug page: https://assetmemo.bio/drug/brl-305#upcoming-events\nRegi
 stry record: https://clinicaltrials.gov/study/NCT07248176
URL:https://assetmemo.bio/drug/brl-305#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
